Global Liver Disease Drug Market Research Report 2016

December 2016 | 111 pages | ID: G2156FAB2D1EN
QYResearch

Abstracts

Notes:

Production, means the output of Liver Disease Drug

Revenue, means the sales value of Liver Disease Drug

This report studies Liver Disease Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Bayer Schering AG
• Biotest
• Bristol-Myers Squibb
• Eli Lilly
• Glaxosmithkline PlC
• Merck & Co
• Pfizer
• Roche
• Valeant Pharmaceuticals International, Inc
• Chia Tai Tianqing Pharmaceutical Group
• Fujian Cosunter Pharmaceutical Company
• Beijing Sl Pharmaceutical Co., Ltd.
• Inner Mongolia Furui Medical Science Co. Ltd.

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Liver Disease Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Liver Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Liver Disease Drug Market Research Report 2016

1 LIVER DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Liver Disease Drug
1.2 Liver Disease Drug Segment by Type
  1.2.1 Global Production Market Share of Liver Disease Drug by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Liver Disease Drug Segment by Application
  1.3.1 Liver Disease Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Liver Disease Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Liver Disease Drug (2011-2021)

2 GLOBAL LIVER DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Liver Disease Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Liver Disease Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Liver Disease Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Liver Disease Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Liver Disease Drug Market Competitive Situation and Trends
  2.5.1 Liver Disease Drug Market Concentration Rate
  2.5.2 Liver Disease Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL LIVER DISEASE DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Liver Disease Drug Production and Market Share by Region (2011-2016)
3.2 Global Liver Disease Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL LIVER DISEASE DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Liver Disease Drug Consumption by Regions (2011-2016)
4.2 North America Liver Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Liver Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Liver Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Liver Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Liver Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Liver Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL LIVER DISEASE DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Liver Disease Drug Production and Market Share by Type (2011-2016)
5.2 Global Liver Disease Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Liver Disease Drug Price by Type (2011-2016)
5.4 Global Liver Disease Drug Production Growth by Type (2011-2016)

6 GLOBAL LIVER DISEASE DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Liver Disease Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Liver Disease Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL LIVER DISEASE DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Bayer Schering AG
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Liver Disease Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Bayer Schering AG Liver Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Biotest
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Liver Disease Drug Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Biotest Liver Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Bristol-Myers Squibb
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Liver Disease Drug Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Bristol-Myers Squibb Liver Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Eli Lilly
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Liver Disease Drug Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Eli Lilly Liver Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Glaxosmithkline PlC
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Liver Disease Drug Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Glaxosmithkline PlC Liver Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Merck & Co
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Liver Disease Drug Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Merck & Co Liver Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Pfizer
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Liver Disease Drug Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Pfizer Liver Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Roche
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Liver Disease Drug Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Roche Liver Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Valeant Pharmaceuticals International, Inc
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Liver Disease Drug Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Valeant Pharmaceuticals International, Inc Liver Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Chia Tai Tianqing Pharmaceutical Group
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Liver Disease Drug Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Chia Tai Tianqing Pharmaceutical Group Liver Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Fujian Cosunter Pharmaceutical Company
7.12 Beijing Sl Pharmaceutical Co., Ltd.
7.13 Inner Mongolia Furui Medical Science Co. Ltd.

8 LIVER DISEASE DRUG MANUFACTURING COST ANALYSIS

8.1 Liver Disease Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Liver Disease Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Liver Disease Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Liver Disease Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL LIVER DISEASE DRUG MARKET FORECAST (2016-2021)

12.1 Global Liver Disease Drug Production, Revenue Forecast (2016-2021)
12.2 Global Liver Disease Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Liver Disease Drug Production Forecast by Type (2016-2021)
12.4 Global Liver Disease Drug Consumption Forecast by Application (2016-2021)
12.5 Liver Disease Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Liver Disease Drug
Figure Global Production Market Share of Liver Disease Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Liver Disease Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Liver Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Liver Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Liver Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Liver Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Liver Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Liver Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Liver Disease Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Liver Disease Drug Production of Key Manufacturers (2015 and 2016)
Table Global Liver Disease Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Liver Disease Drug Production Share by Manufacturers
Figure 2016 Liver Disease Drug Production Share by Manufacturers
Table Global Liver Disease Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Liver Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Liver Disease Drug Revenue Share by Manufacturers
Table 2016 Global Liver Disease Drug Revenue Share by Manufacturers
Table Global Market Liver Disease Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Liver Disease Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Liver Disease Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Liver Disease Drug Product Type
Figure Liver Disease Drug Market Share of Top 3 Manufacturers
Figure Liver Disease Drug Market Share of Top 5 Manufacturers
Table Global Liver Disease Drug Production by Regions (2011-2016)
Figure Global Liver Disease Drug Production and Market Share by Regions (2011-2016)
Figure Global Liver Disease Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Liver Disease Drug Production Market Share by Regions
Table Global Liver Disease Drug Revenue by Regions (2011-2016)
Table Global Liver Disease Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Liver Disease Drug Revenue Market Share by Regions
Table Global Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Liver Disease Drug Consumption Market by Regions (2011-2016)
Table Global Liver Disease Drug Consumption Market Share by Regions (2011-2016)
Figure Global Liver Disease Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Liver Disease Drug Consumption Market Share by Regions
Table North America Liver Disease Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Liver Disease Drug Production, Consumption, Import & Export (2011-2016)
Table China Liver Disease Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Liver Disease Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Liver Disease Drug Production, Consumption, Import & Export (2011-2016)
Table India Liver Disease Drug Production, Consumption, Import & Export (2011-2016)
Table Global Liver Disease Drug Production by Type (2011-2016)
Table Global Liver Disease Drug Production Share by Type (2011-2016)
Figure Production Market Share of Liver Disease Drug by Type (2011-2016)
Figure 2015 Production Market Share of Liver Disease Drug by Type
Table Global Liver Disease Drug Revenue by Type (2011-2016)
Table Global Liver Disease Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Liver Disease Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Liver Disease Drug by Type
Table Global Liver Disease Drug Price by Type (2011-2016)
Figure Global Liver Disease Drug Production Growth by Type (2011-2016)
Table Global Liver Disease Drug Consumption by Application (2011-2016)
Table Global Liver Disease Drug Consumption Market Share by Application (2011-2016)
Figure Global Liver Disease Drug Consumption Market Share by Application in 2015
Table Global Liver Disease Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Liver Disease Drug Consumption Growth Rate by Application (2011-2016)
Table Bayer Schering AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Schering AG Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Schering AG Liver Disease Drug Market Share (2011-2016)
Table Biotest Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biotest Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biotest Liver Disease Drug Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Liver Disease Drug Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Liver Disease Drug Market Share (2011-2016)
Table Glaxosmithkline PlC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Glaxosmithkline PlC Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Glaxosmithkline PlC Liver Disease Drug Market Share (2011-2016)
Table Merck & Co Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co Liver Disease Drug Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Liver Disease Drug Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Liver Disease Drug Market Share (2011-2016)
Table Valeant Pharmaceuticals International, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals International, Inc Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Valeant Pharmaceuticals International, Inc Liver Disease Drug Market Share (2011-2016)
Table Chia Tai Tianqing Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chia Tai Tianqing Pharmaceutical Group Liver Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Chia Tai Tianqing Pharmaceutical Group Liver Disease Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liver Disease Drug
Figure Manufacturing Process Analysis of Liver Disease Drug
Figure Liver Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Liver Disease Drug Major Manufacturers in 2015
Table Major Buyers of Liver Disease Drug
Table Distributors/Traders List
Figure Global Liver Disease Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Liver Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Liver Disease Drug Production Forecast by Regions (2016-2021)
Table Global Liver Disease Drug Consumption Forecast by Regions (2016-2021)
Table Global Liver Disease Drug Production Forecast by Type (2016-2021)
Table Global Liver Disease Drug Consumption Forecast by Application (2016-2021)